Celts welcome Celgene’s Patient access scheme for Vidaza, too
13 September 2011
Francesca Bruce
Please Login to read the full article.
13 September 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- Scots choose chewy Lipitor but refuse Zytiga, Sycrest and Gilenya
- Scotland says yes to BI/Lilly's Tradjenta and Lilly's Bydureon
- Scotland says no to Halaven for breast cancer and yes to Levitra for erectile dysfunction
- Patient access scheme prompts NICE U-turn on Novartis' Tasigna, while BMS will appeal against no for Sprycel
ANALYSIS
Other Informa Analysis
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- Piramal: regulatory overhaul would help India tackle disease challenges
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
